Literature DB >> 26998622

Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.

Ahad Mokhtarzadeh1,2,3, Abbas Alibakhshi4, Hajar Yaghoobi5, Maryam Hashemi6, Maryam Hejazi7, Mohammad Ramezani3,6.   

Abstract

INTRODUCTION: Gene therapy mainly depends on the use of appropriate delivery vehicles with no induction of immune responses and toxicity. The limitations of viral gene carriers such as induction of immunogenicity, random integration in the genome of the host, limitations in the size, has led to a movement toward non-viral systems with much safer properties. Biodegradable and biocompatible polymeric nanocarriers due to several unique properties such as excellent biocompatibility, prolonged gene circulation time, prevented gene degradation, passive targeting by using the enhanced permeability and retention (EPR) effect, and possibility of modulating polymers structure to obtain desirable therapeutic efficacy, are among the most promising systems for gene delivery. However, biodegradable gene delivery systems have some limitations such as inadequate stability and slow release of therapeutics which have to be overcome. Thus, a variety of advanced functional biodegradable delivery systems with more efficient gene delivery activity has recently been introduced. AREAS COVERED: This review summarizes different aspects of biodegradable and biocompatible nano carriers including formulation, mechanism of intracellular uptake, various potential applications of biodegradable nanoparticles and finally recent studies on the therapeutic efficacy of these nanoparticles in sustained delivery of genes. EXPERT OPINION: Biocompatible and biodegradable polymers will play a necessary and important role in developing new and safe carriers for oligonucleotide delivery. More working and the development of optimized polymers will reveal more their efficacy in the treatment of patients via helping in better gene therapy.

Entities:  

Keywords:  Gene therapy; biocompatible; biodegradable; polymeric nanocarriers

Mesh:

Substances:

Year:  2016        PMID: 26998622     DOI: 10.1517/14712598.2016.1169269

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  13 in total

1.  Nanoformulated ABT-199 to effectively target Bcl-2 at mitochondrial membrane alleviates airway inflammation by inducing apoptosis.

Authors:  Bao-Ping Tian; Fangyuan Li; Ruiqing Li; Xi Hu; Tian-Wen Lai; Jingxiong Lu; Yun Zhao; Yang Du; Zeyu Liang; Chen Zhu; Wei Shao; Wen Li; Zhi-Hua Chen; Xiaolian Sun; Xiaoyuan Chen; Songmin Ying; Daishun Ling; Huahao Shen
Journal:  Biomaterials       Date:  2018-06-18       Impact factor: 12.479

Review 2.  Biomedical Applications of Polyhydroxyalkanoates.

Authors:  Subhasree Ray; Vipin Chandra Kalia
Journal:  Indian J Microbiol       Date:  2017-04-22       Impact factor: 2.461

Review 3.  Potential applications and human biosafety of nanomaterials used in nanomedicine.

Authors:  Hong Su; Yafei Wang; Yuanliang Gu; Linda Bowman; Jinshun Zhao; Min Ding
Journal:  J Appl Toxicol       Date:  2017-06-06       Impact factor: 3.446

Review 4.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

5.  A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA.

Authors:  Cong Luo; Lei Miao; Yi Zhao; Sara Musetti; Yuhua Wang; Kai Shi; Leaf Huang
Journal:  Biomaterials       Date:  2016-06-16       Impact factor: 12.479

6.  In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer.

Authors:  Victor Hugo Bermúdez-Morales; Geny Fierros-Zarate; Celina García-Meléndrez; Juan Manuel Alcocer-Gonzalez; Ausencio Morales-Ortega; Oscar Peralta-Zaragoza; Kirvis Torres-Poveda; Ana Isabel Burguete-García; Eva Hernández-Márquez; Vicente Madrid-Marina
Journal:  J Cancer       Date:  2016-09-27       Impact factor: 4.207

7.  A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH.

Authors:  Mei Lin; Junxing Huang; Xingmao Jiang; Jia Zhang; Hong Yu; Jun Ye; Dongsheng Zhang
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

8.  Nanoparticles of Titanium and Zinc Oxides as Novel Agents in Tumor Treatment: a Review.

Authors:  Janusz Bogdan; Joanna Pławińska-Czarnak; Joanna Zarzyńska
Journal:  Nanoscale Res Lett       Date:  2017-03-27       Impact factor: 4.703

9.  In vivo Bio-Distribution and Toxicity Evaluation of Polymeric and Lipid-Based Nanoparticles: A Potential Approach for Chronic Diseases Treatment.

Authors:  João Fonseca-Gomes; Joana A Loureiro; Maria José Diógenes; Maria Carmo Pereira; Sara R Tanqueiro; Francisco M Mouro; Pedro Ruivo; Tânia Carvalho; Ana M Sebastião
Journal:  Int J Nanomedicine       Date:  2020-11-05

10.  Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone.

Authors:  Liroy Lugasi; Igor Grinberg; Rivka Sabag; Ravit Madar; Haim Einat; Shlomo Margel
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.